Skip to main content
Clinical Trials/ACTRN12617001473358
ACTRN12617001473358
Recruiting
Phase 4

A randomized, controlled trial to evaluate the effect of Diazoxide and Glucagon for the treatment of significant hypoglycaemia in neonates: The GLAD study

Dr Lydia Kennedy0 sites100 target enrollmentOctober 18, 2017

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Hypoglycaemia
Sponsor
Dr Lydia Kennedy
Enrollment
100
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 18, 2017
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Lydia Kennedy

Eligibility Criteria

Inclusion Criteria

  • Infants of diabetic mothers (any type of diabetes) who satisfy ALL of the following:
  • 1\.more than or equal to 35 weeks gestation
  • 2\.Birth\-weight more than 2\.2 kg
  • 3\.Less than 12 hours old
  • 4\.Unlikely to require admission to NICU for any other reason e.g. respiratory distress
  • 5\.Diagnosis of neonatal hypoglycaemia with 10% Glucose infusion rate 90ml/kg/day and BGL less than 3\.5mmol/

Exclusion Criteria

  • Major congenital abnormalities

Outcomes

Primary Outcomes

Not specified

Similar Trials